the obvious reason: their big-spending pharmaceutical advertisers would drop them like hot potatoes..
in a news release, the drug's manufacturer, amgen, said the list price will be 5 a month or ,900 annually. costs to patients may vary depending on insurance..
the financial times and its journalism are subject to a self-regulation regime under the ft editorial code of practice:. german chancellor angela merkel (bottom left) was straightforward when she said enlargment was not on the table at the sofia summit ..